These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28078168)

  • 1. Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders.
    Harstad E; Sideridis G; Sherritt L; Shrier LA; Ziemnik R; Levy S
    J Caffeine Res; 2016 Dec; 6(4):141-147. PubMed ID: 28078168
    [No Abstract]   [Full Text] [Related]  

  • 2. Caffeine use disorder: An item-response theory analysis of proposed DSM-5 criteria.
    Ágoston C; Urbán R; Richman MJ; Demetrovics Z
    Addict Behav; 2018 Jun; 81():109-116. PubMed ID: 29454178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of Caffeine Use Disorder, Caffeine Withdrawal, Harm and Help-seeking in New Zealand: A cross-sectional survey.
    Booth N; Saxton J; Rodda SN
    Addict Behav; 2020 Oct; 109():106470. PubMed ID: 32485545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual cannabis and alcohol use disorders in young adults: Problems magnified.
    Hayaki J; Anderson BJ; Stein MD
    Subst Abus; 2016; 37(4):579-583. PubMed ID: 27070725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.
    Matson TE; Lapham GT; Bobb JF; Oliver M; Hallgren KA; Williams EC; Bradley KA
    JAMA Netw Open; 2022 Nov; 5(11):e2239772. PubMed ID: 36318205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study.
    Abdoli F; Davoudi M; Momeni F; Djafari F; Dolatshahi B; Hosseinzadeh S; Aliyaki H; Khalili Z
    Sci Rep; 2024 Apr; 14(1):7644. PubMed ID: 38561480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care.
    Levy S; Weitzman ER; Marin AC; Magane KM; Wisk LE; Shrier LA
    Subst Abus; 2021; 42(3):388-395. PubMed ID: 32814009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom endorsement of alcohol and other substance abuse and dependence criteria among American-Indian adolescents in residential substance abuse treatment.
    Fickenscher A; Novins DK; Beals J
    J Addict Dis; 2005; 24(4):65-78. PubMed ID: 16368657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Dependence Criteria for Caffeine.
    Striley CL; Griffiths RR; Cottler LB
    J Caffeine Res; 2011 Dec; 1(4):219-225. PubMed ID: 24761264
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians.
    Copeland WE; Hill S; Costello EJ; Shanahan L
    J Am Acad Child Adolesc Psychiatry; 2017 Feb; 56(2):124-132.e2. PubMed ID: 28117058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of current DSM-IV and proposed DSM-5 diagnostic criteria for cocaine use disorders.
    Proctor SL; Kopak AM; Hoffmann NG
    Addict Behav; 2012 Jun; 37(6):722-8. PubMed ID: 22386237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Comorbidity Between Substance Use and Mental Health in Adolescents: Two Sides of the Same Coin.
    Fernández-Artamendi S; Martínez-Loredo V; López-Núñez C
    Psicothema; 2021 Feb; 33(1):36-43. PubMed ID: 33453734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine dependence in teenagers.
    Bernstein GA; Carroll ME; Thuras PD; Cosgrove KP; Roth ME
    Drug Alcohol Depend; 2002 Mar; 66(1):1-6. PubMed ID: 11850129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functioning of cannabis abuse and dependence criteria across two different countries: the United States and The Netherlands.
    Delforterie M; Creemers H; Agrawal A; Lynskey M; Jak S; van der Ende J; Verhulst F; Huizink A
    Subst Use Misuse; 2015 Jan; 50(2):242-50. PubMed ID: 25363693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endorsement of DSM-IV dependence criteria among caffeine users.
    Hughes JR; Oliveto AH; Liguori A; Carpenter J; Howard T
    Drug Alcohol Depend; 1998 Oct; 52(2):99-107. PubMed ID: 9800139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.